Multiplexed IHC/ISH Using an Automated Slide Staining Platform

In this GEN webinar, Edward Abril, research specialist at The University of Arizona Cancer Center, will describe how the multiplexing platform technology is used in a research IHC core facility, providing researchers with high-quality, reproducible results for diseases such as colorectal and prostate cancer. Adrian Murillo, scientist at Ventana Medical Systems—a member of the Roche Group, will provide information on new techniques and reagents for multiplexing labeling assays and the multitude of applications for the DISCOVERY ULTRA platform.